Navigation Links
GPhA's 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
Date:8/30/2007

Thurs.-Fri., Sept. 6-7, Mandarin Oriental, Washington, D.C.

ARLINGTON, Va., Aug. 30 /PRNewswire/ -- Three leading generic industry CEOs, along with top Wall Street analysts and key Food and Drug Administration (FDA) and other government officials, will headline the Generic Pharmaceutical Association's (GPhA) Annual Policy Conference on September 6-7, 2007. The conference, "Generics: Prescription for Affordable Health Care," will focus on the legislative, regulatory and business issues that will shape the generic industry in the coming years.

"This conference will look at the wide range of issues affecting the generic industry's efforts to provide consumers with timely access to affordable medicines," said Kathleen Jaeger, GPhA President and CEO. "From regulations to legislation, the industry is facing a series of unique opportunities and challenges."

The conference features keynote presentations from Hospira, Inc. Chairman and CEO Christopher Begley, Mylan Laboratories CEO Robert Coury, and Actavis President and CEO Robert Wessman.

Conference speakers also include U.S. Representatives Henry Waxman (D-CA) and Frank Pallone (D-NJ), FDA Deputy Commissioner Dr. Janet Woodcock, FDA Chief Counsel Sheldon Bradshaw, IMS Health Vice President Doug Long, UBS Warburg Healthcare Banking Director Tommy Erdei, Lehman Brothers Senior Vice President Richard Silver, and Roundtable Healthcare Partners Senior Partner David Koo, among other industry experts. In addition, the conference has special track sessions on federal legislation and legal issues, which will take place on September 6.

GPhA's Annual Policy Conference will be held at the Mandarin Oriental Hotel, 1330 Maryland Avenue, S.W., in Washington, D.C. The conference begins at 8 a.m. on both days. The conference agenda is available online at http://www.gphaonline.org.

For registration information, go to http://www.gphaonline.org. Credentialed media can register at no charge by contacting Andrea Hofelich at 703-647-2495.

GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk active pharmaceutical chemicals, and suppliers of other goods and services to the generic drug industry. Generics represent 63% of the total prescriptions dispensed in the United States, but only 20% of all dollars spent on prescription drugs. For further information, please contact GPhA at 703-647-2480, or visit our web site at http://www.gphaonline.org.


'/>"/>
SOURCE GPhA
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Annual PSA screening reduces risk of prostate cancer deaths
2. Low turnover by Diabetics for free annual checkup
3. UK Spends ?7.3 Billion Annually On Malnutrition Cost
4. Annual Dental Checkups in Children Lagging Behind
5. Annual Budget 2006: Health And Education Sector Receive A Boost
6. Breast cancer survivors slacken on mandated annual mammograms
7. Brazil & Kenya Seek Support For A New Resolution At WHO’s Annual Mee
8. Medical Tourism can Fetch Rs.100 bn Annually by 2012
9. Annual Conference Of Plastic Surgeons In US To Focus On The Future Of Plastic Surgery
10. Jamaica Sees 1000 New Cases of HIV Annually
11. More Indians Die of Rabies Annually
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... Wesley Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... Chapel is holding a treadmill relay – Miles by Moonlight to raise money for ... by donating $300 or more. , Teams will work together to keep their ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
(Date:9/18/2017)... R.I. , Sept. 18, 2017 /PRNewswire/ ... the fields of bioinformatics and immune engineering, ... a protective avian influenza A (H7N9) vaccine. ... distantly related to seasonal influenza and presents ... rely on prior exposure to be effective. ...
Breaking Medicine Technology: